Skip to main content

Advertisement

Log in

Mediation effect of hepatitis B and C on mortality

  • INFECTIOUS DISEASES
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

Hepatitis B (HBV) and C (HCV) viruses cause many liver diseases. To move beyond statistical interaction, we aimed to assess the coordinated effect of the two viruses on mortality using mediation analyses. A prospective cohort study of 3837 residents in Taiwan examined participants seropositive for hepatitis B, of which 181 subjects (4.7 %) were co-infected by HCV and 589 died during follow-up. Mediation analyses for cause-specific mortality were performed using Cox proportional hazards model. Follow-up HBV viral load was inversely correlated with baseline HCV viral load (r2 = −0.074; P < 0.001). For HCV serum viral load increasing from 800 to 404,000 IU/mL (minimum to median) at baseline, the effect of HCV mediated through HBV viral load decreased the all-cause mortality with a hazard ratio (HR) of 0.89 (95 % confidence interval (CI) 0.85, 0.94; P < 0.001), and the effect independent of HBV viral load had an opposite HR of 1.25 (95 % CI 0.98, 1.60; P = 0.08). The protective mediation effects of HCV viral load through HBV DNA level were observed in mortality from causes specific to liver-related diseases and liver cancer, but not in that from non-liver-related diseases. Our findings suggest a suppressive effect of HCV on mortality mediated through decreasing HBV viral load.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295(1):65–73. doi:10.1001/jama.295.1.65.

    Article  CAS  PubMed  Google Scholar 

  2. Oh JK, Shin HR, Lim MK, et al. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study. BMC Cancer. 2012;12:452. doi:10.1186/1471-2407-12-452.

    Article  PubMed  PubMed Central  Google Scholar 

  3. (WHO) WHO http://www.euro.who.int/en/health-topics/communicable-diseases/hepatitis/data-and-statistics (2014)

  4. Lee MH, Yang HI, Lu SN, et al. Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. J Infect Dis. 2012;206(4):469–77. doi:10.1093/infdis/jis385.

    Article  PubMed  Google Scholar 

  5. Giordano TP, Henderson L, Landgren O, et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA. 2007;297(18):2010–7. doi:10.1001/jama.297.18.2010.

    Article  CAS  PubMed  Google Scholar 

  6. Chen CJ, Wang LY, Yu MW. Epidemiology of hepatitis B virus infection in the Asia-Pacific region. J Gastroenterol Hepatol. 2000;15(Suppl):E3–6.

    Article  PubMed  Google Scholar 

  7. Lu SN, Chue PY, Chen IL, et al. Incidence of hepatitis C infection in a hepatitis C endemic township in southern Taiwan. Kaohsiung J Med Sci. 1997;13(10):605–8.

    CAS  PubMed  Google Scholar 

  8. Sun CA, Chen HC, Lu CF, et al. Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide survey. J Med Virol. 1999;59(3):290–6.

    Article  CAS  PubMed  Google Scholar 

  9. Wu JS, Lu CF, Chou WH, et al. High prevalence of hepatitis C virus infection in aborigines in Taiwan. Jpn J Med Sci Biol. 1992;45(4):165–74.

    Article  CAS  PubMed  Google Scholar 

  10. Lu SN, Chen HC, Tang CM, et al. Prevalence and manifestations of hepatitis C seropositivity in children in an endemic area. Pediatr Infect Dis J. 1998;17(2):142–5.

    Article  CAS  PubMed  Google Scholar 

  11. Liu Z, Hou J. Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection. Int J Med Sci. 2006;3(2):57–62.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Sun CA, Farzadegan H, You SL, et al. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan. Cancer Epidemiol Biomark Prev. 1996;5(3):173–8.

    CAS  Google Scholar 

  13. Shi J, Zhu L, Liu S, Xie WF. A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. Br J Cancer. 2005;92(3):607–12. doi:10.1038/sj.bjc.6602333.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Sun CA, Wu DM, Lin CC, et al. Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan. Am J Epidemiol. 2003;157(8):674–82.

    Article  PubMed  Google Scholar 

  15. Huang YT, Jen CL, Yang HI, et al. Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C. J Clin Oncol. 2011;29(27):3643–50. doi:10.1200/JCO.2011.36.2335.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Kruse RL, Kramer JR, Tyson GL, et al. Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients. Hepatology. 2014;60(6):1871–8. doi:10.1002/hep.27337.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173–82.

    Article  CAS  PubMed  Google Scholar 

  18. MacKinnon DP. Introduction to statistical mediation analysis. New York: Lawrence Erlbaum Associates; 2008.

    Google Scholar 

  19. Robins JM, Greenland S. Identifiability and exchangeability for direct and indirect effects. Epidemiology. 1992;3(2):143–55.

    Article  CAS  PubMed  Google Scholar 

  20. VanderWeele TJ, Asomaning K, Tchetgen Tchetgen EJ, et al. Genetic variants on 15q25.1, smoking, and lung cancer: an assessment of mediation and interaction. Am J Epidemiol. 2012;175(10):1013–20. doi:10.1093/aje/kwr467.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Chen CL, Yang HI, Yang WS, et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology. 2008;135(1):111–21. doi:10.1053/j.gastro.2008.03.073.

    Article  CAS  PubMed  Google Scholar 

  22. Iloeje UH, Yang HI, Jen CL, et al. Risk and predictors of mortality associated with chronic hepatitis B infection. Clin Gastroenterol Hepatol. 2007;5(8):921–31. doi:10.1016/j.cgh.2007.06.015.

    Article  PubMed  Google Scholar 

  23. Lee MH, Yang HI, Lu SN, et al. Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study. J Clin Oncol. 2010;28(30):4587–93. doi:10.1200/JCO.2010.29.1500.

    Article  PubMed  Google Scholar 

  24. Cox DR. Regression models and life-tables. J R Stat Soc B. 1972;34(2):187–220.

    Google Scholar 

  25. VanderWeele TJ. Causal mediation analysis with survival data. Epidemiology. 2011;22(4):582–5. doi:10.1097/EDE.0b013e31821db37e.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Vanderweele TJ, Vansteelandt S. Odds ratios for mediation analysis for a dichotomous outcome. Am J Epidemiol. 2010;172(12):1339–48. doi:10.1093/aje/kwq332.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Robins JM. Semantics of causal DAG models and the identification of direct and indirect effects. In: Geen P, Hjort NL, Richardson S, editors. New York: Oxford University Press; 2003

  28. Tsiquaye KN, Portmann B, Tovey G, et al. Non-A, non-B hepatitis in persistent carriers of hepatitis B virus. J Med Virol. 1983;11(3):179–89.

    Article  CAS  PubMed  Google Scholar 

  29. Koike K, Yasuda K, Yotsuyanagi H, et al. Dominant replication of either virus in dual infection with hepatitis viruses B and C. J Med Virol. 1995;45(2):236–9.

    Article  CAS  PubMed  Google Scholar 

  30. Liaw YF. Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology. 1995;22(4 Pt 1):1101–8.

    CAS  PubMed  Google Scholar 

  31. Shih CM, Lo SJ, Miyamura T, Chen SY, Lee YH. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol. 1993;67(10):5823–32.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Schuttler CG, Fiedler N, Schmidt K, Repp R, Gerlich WH, Schaefer S. Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein. J Hepatol. 2002;37(6):855–62.

    Article  CAS  PubMed  Google Scholar 

  33. Bellecave P, Gouttenoire J, Gajer M, et al. Hepatitis B and C virus coinfection: a novel model system reveals the absence of direct viral interference. Hepatology. 2009;50(1):46–55. doi:10.1002/hep.22951.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

NIH/NCI R03 CA182937-02, NIH/NIA R01 AG048825-01 and Salomon Research Fund at Brown University.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yen-Tsung Huang.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 175 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huang, YT., Freeman, J.R., Yang, HI. et al. Mediation effect of hepatitis B and C on mortality. Eur J Epidemiol 31, 625–633 (2016). https://doi.org/10.1007/s10654-016-0118-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-016-0118-x

Keywords

Navigation